Overview | Agenda/Faculty Materials | Promotional Opportunities
Speaking Proposals | Administration | Contact Us | Past Events | Home




THE 2010 COMPARATIVE EFFECTIVENESS SUMMIT CONTENT IS NOW AVAILABLE IN VARIOUS POST CONFERENCE FORMATS

The 2010 Comparative Effectiveness Summit conference content is now available in a variety of formats.

You may purchase the Summit streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

YOU CAN PURCHASE JUST THE 2010 COMPARATIVE EFFECTIVENESS SUMMIT CONTENT AS FOLLOWS:

Online Archive of 2010 Comparative Effectiveness Summit Presentations today!
Complete conference: $395
Order Now

Flash Drive of 2010 Comparative Effectiveness Summit Presentations today!
$245
Order Now

FINALLY YOU MAY PURCHASE 2010 COMPARATIVE EFFECTIVENESS SUMMIT INDIVIDUAL PRESENTATIONS:
Click here to purchase individual presentations for $19.95 in online archive format (6 months of access - 24/7).






SECOND NATIONAL COMPARATIVE EFFECTIVENESS SUMMIT

September 13 - 14, 2010

ONSITE
Crystal Gateway Marriott
Arlington, VA

ONLINE
In your own office or home live via the Internet with 24/7 access for six months


COMPARATIVE EFFECTIVENESS SUMMIT ONLINE ARCHIVE LOG IN
Click here to log into Comparative Effectiveness video archive.


FEATURING SPECIAL SESSIONS ON
  • Role of the Patient Centered Outcomes Research Institute (PCORI)
  • Comparative Effectiveness Research: The Legislative History and Future
  • Overview of Federal Stimulus Funding of CER
  • How States are Already Using Comparative and Cost-effective Research
  • Methods and Data Infrastructure Needed for CER
  • The Role of HIT in Comparative Effectiveness Research
  • Comparative Effectiveness versus Cost-Effectiveness
  • The Relationship between AHRQ and CMS through the Lens of CER
  • Comparative Effectiveness Research and the FDA
  • Balancing Comparative Effectiveness Research and Personalized Medicine
  • Initiatives under way to Develop Evidence of CER and put it into Practice
  • The Impact of CER on Health and Health Care Spending

  • AND TRACKS ON
  • CER for Public Programs
  • CER for Employers and Health Plans
  • CER for Pharma and Device Manufacturers
  • CER for Healthcare Providers

  • FREE SUBSCRIPTION TO MONTHLY
    COMPARATIVE EFFECTIVENESS e-NEWSLETTER

    Click here to subscribe to a monthly Accountable Care Update e-Newsletter, one of a family of free e-Newsletters providing a complimentary video presentation and regularly updated news and key resources on major health care issues. To view and subscribe to other e-Newsletters on patient safety, ACOs, Medicaid, and readmissions, go to www.HealthCareeNewsletters.com.

    GRANTORS
    ADDITIONAL GRANTOR

    MEDIA PARTNERS










    SECOND NATIONAL COMPARATIVE EFFECTIVENESS SUMMIT
    September 13 - 14, 2010

    ONSITE
    Crystal Gateway Marriott
    Arlington, VA


    OR
    ONLINE
    In your own office or home live via the Internet
    with 24/7 access for six months


    KEYNOTE SPEAKERS

    Carolyn M. Clancy, MD
    Director, Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services, Washington, DC

    Francis S. Collins, MD, PhD
    Director, National Institutes of Health, Former Director, National Human Genome Research Institute, Author, The Language of Life: DNA and the Revolution in Personalized Medicine (2010), Bethesda, MD

    Kavita Patel, MD, MSHS
    Director, Health Policy Program, New America Foundation, Former Senior Adviser to Valerie Jarrett, the White House, Former Deputy Staff Director, Senate Health Subcommittee, Washington, DC

    Gail Wilensky, PhD
    Senior Fellow, Project HOPE, Former Administrator, Health Care Financing Administration, Washington, DC
    SUMMIT CHAIR

    John Iglehart
    Founding Editor, Health Affairs, National Correspondent, New England Journal of Medicine, Washington, DC
    LEGISLATIVE HISTORY AND FUTURE

    Stephen Cha, MD, MHS
    Professional Staff, Committee on Energy and Commerce, United States House of Representatives, Washington, DC

    Keith Flanagan, Esq.
    Health Counsel to Ranking Member Enzi, Health Committee, United States Senate, Washington, DC


    Sarah Kuehl (Invited)
    Professional Staff (Conrad), Budget Committee, United States Senate, Washington, DC
    COVERAGE AND PAYMENT POLICY



    Elise Berliner, PhD
    Director, Technology Assessment Program, Agency for Healthcare Research & Quality, Washington, DC

    Louis B. Jacques, MD
    Director, Coverage & Analysis Group, Office of Clinical Standards and Quality, Centers for Medicare & Medicaid Services, Washington, DC


    Tamara Syrek Jensen, J.D.
    Deputy Director, Coverage and Analysis Group, Office of Clinical Standards and Quality, Centers for Medicare & Medicaid Services, Washington, DC

    Susan G. Merewitz, Esq.
    Former Senior Attorney, Agency for Healthcare Research and Quality, Office of General Counsel, Public Health Division, Department of Health and Human Services, Rockville, MD

    Jason B. Caron, Esq.
    Associate, EpsteinBeckerGreen, Washington, DC (Moderator)
    CER FOR PUBLIC PROGRAMS


    Elizabeth Docteur
    Vice President and Director of Policy Analysis, Center for Studying Health System Change, Washington, DC

    Joel Kupersmith, MD
    Chief Research and Development Officer, Veterans Administration, Washington, DC

    Judy Zerzan, MD, MPH
    Colorado Medicaid Medical Director, Colorado Department of Health Care Policy, Denver, CO
    CER FOR EMPLOYERS AND HEALTH PLANS

    Naomi Aronson, PhD
    Executive Director, Technology Evaluation Center, Blue Cross Blue Shield Association, Chicago, IL

    David V. Axene, FSA, FCA, MAAA
    Founder and President, Axene Health Partners, LLC, Winchester, CA
    CER FOR HEALTHCARE PROVIDERS

    Robert M. Centor, MD, FACP
    Associate Dean, Huntsville Regional Medical Campus, University of Alabama at Birmingham, Huntsville, AL

    Ruth Shaber, MD
    Medical Director, Kaiser Permanente Care Management Institute, Oakland, CA
    CER FOR PHARMA AND DEVICE MANUFACTURERS

    Teresa Lee, JD, MPH
    Senior Vice President, Advanced Medical Technology Association, Washington, DC

    Newell McElwee, PharmD, MSPH
    Executive Director, U.S. Outcomes Research, Merck & Co., Former Vice-President of Outcomes Research, Pfizer, Washington, DC

    Robert Temple, MD
    Associate Director for Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, Washington, DC
    AND THE FOLLOWING NATIONAL EXPERTS

    Jerry Avorn, MD
    Professor of Medicine, Harvard Medical School, Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Author, "Debate About Funding Comparative Effectiveness Research," New England Journal of Medicine, Boston, MA

    Mark Gibson
    Director, Center for Evidence-Based Policy, Oregon Health and Science University, Program Officer, Milbank Memorial Fund, Former Chief of Staff, Oregon Senate President John Kitzhaber, Portland, OR

    Scott Gottlieb, MD
    Medical Internist, Stamford Hospital, Former Deputy Commissioner for Medical and Scientific Affairs, FDA, Former Senior Adviser to the Administrator, CMS, Washington, DC

    David R. Hunt, MD, FACS
    Chief Medical Officer, Office of the National Coordinator, Department of Health and Human Services, Washington, DC

    Amy M. Miller, PhD
    Public Policy Director, Personalized Medicine Coalition, Washington, DC

    Tomas J. Philipson, PhD
    Daniel Levin Professor of Public Policy Studies, Harris School, Associate Faculty Member, Department of Economics, University of Chicago, Chicago, IL

    Eugene C. Rich, MD
    Senior Fellow and Director, Center for Health Care Effectiveness, Mathematica Policy Research, Washington, DC

    Sean Tunis, MD, MSc
    Founder and Director, Center for Medical Technology Policy, Former Director, Office of Clinical Standards and Quality and Chief Medical Officer, Centers for Medicare and Medicaid Services, Baltimore, MD

    Milton Weinstein, PhD
    Henry J. Kaiser Professor of Health Policy and Management, Department of Health Policy and Management and Department of Biostatistics, Harvard School of Public Health, Boston, MA
    ATTENDANCE OPTIONS
    TRADITIONAL CONFERENCE ATTENDANCE
    Register for Preconference Comparative Effectiveness Preconference and/or Conference.






    We subscribe to the HONcode principles of the HON Foundation. Click to verify.




    LIVE AND ARCHIVED INTERNET ATTENDANCE
    Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

    The archived conference includes speaker videos and coordinated PowerPoint presentations.

    Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office





    INTERNET INTERFACE SAMPLE

    Click here for a sample stream



    Overview | Agenda/Faculty Materials | Promotional Opportunities
    Speaking Proposals | Administration | Contact Us | Past Events | Home




    © Health Care Conference Administrators
    Contact Webmaster